PuSH - Publikationsserver des Helmholtz Zentrums München

Gieselmann, L.* ; DeLaitsch, A.T.* ; Rohde, M.* ; Radford, C.* ; Worczinski, J.* ; Momot, A.* ; Ahmadov, E.* ; Burger, J.A.* ; Havenar-Daughton, C.* ; Deshpande, S.* ; Giovannoni, F.* ; Corti, D.* ; Kreer, C.* ; Ercanoglu, M.S.* ; Schommers, P.* ; Georgiev, I.S.* ; West, A.P.* ; Knüfer, J.* ; Stumpf, R.* ; Kroidl, A.* ; Geldmacher, C.* ; Maganga, L.* ; William, W.* ; Ntinginya, N.E.* ; Hoelscher, M. ; Yang, Z.* ; Wei, Q.* ; Renfrow, M.* ; Green, T.J.* ; Novak, J.* ; van Gils, M.J.* ; Gristick, H.B.* ; Gruell, H.* ; Bloom, J.D.* ; Seaman, M.S.* ; Bjorkman, P.J.* ; Klein, F.*

Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitope.

Nat. Immunol., DOI: 10.1101/2025.09.05.674437 (2026)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Broadly neutralizing antibodies (bNAbs) against HIV-1 can suppress viremia in vivo and inform vaccine development. Here, we characterized 007, a V3 glycan site bNAb exhibiting high levels of antiviral activity against multiclade pseudovirus panels1-3 (GeoMean IC50 = 0.012 μg/mL, breadth = 69%, 217 virus strains) by targeting a N332gp120 glycan-independent V3 epitope, a site of Env vulnerability to which only weakly neutralizing antibodies had previously been identified. Functional analyses demonstrated distinct binding and neutralization profiles compared to classical V3 glycan site bNAbs. A 007 Fab-Env cryo-EM structure revealed contacts with the V3 324GD/NIR327 motif and interactions with N156gp120 and N301gp120 glycans. In contrast to classical V3 bNAbs, 007 binding to Env does not depend on the N332gp120 glycan, rendering it resistant to common escape mutations. Structures of 007 IgG-Env trimer complexes showed two Env trimers crosslinked by three bivalent IgGs, and bivalent 007 IgG was up to ~300-fold more potent than monovalent 007 IgG heterodimer, suggesting a role for avidity in potent neutralization. Finally, in HIV-1ADA-infected humanized mice, 007 caused transient decline of viremia and overcame classical V3 escape mutations, highlighting 007's potential for HIV-1 prevention, therapy, functional cure, and vaccine design.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
ISSN (print) / ISBN 1529-2908
e-ISSN 1529-2916
Zeitschrift Nature Immunology
Verlag Nature Publishing Group
Begutachtungsstatus Peer reviewed
Institut(e) Research Unit Global Health (UGH)